98 related articles for article (PubMed ID: 9058162)
41. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
[TBL] [Abstract][Full Text] [Related]
42. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
Czyzewska J; Guzinska-Ustymowicz K; Kemona A
Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
[TBL] [Abstract][Full Text] [Related]
43. The prognostic significance of c-erbB-2 and p53 protein expressions in gastric carcinoma--a multivariate analysis of prognostic factors.
Kim JP; Oh ST; Hwang TS; Chi JG
J Korean Med Sci; 1994 Jun; 9(3):248-53. PubMed ID: 7993593
[TBL] [Abstract][Full Text] [Related]
44. An immunohistochemical study of c-erbB-2 protein in gastric carcinomas and lymph-node metastases: is the c-erbB-2 protein really a prognostic indicator?
Ohguri T; Sato Y; Koizumi W; Saigenji K; Kameya T
Int J Cancer; 1993 Jan; 53(1):75-9. PubMed ID: 8093216
[TBL] [Abstract][Full Text] [Related]
45. c-erbB-2 oncogene product expression and prognosis in gastric carcinoma.
Hilton DA; West KP
J Clin Pathol; 1992 May; 45(5):454-6. PubMed ID: 1350789
[TBL] [Abstract][Full Text] [Related]
46. [Expression of c-erbB-2 and c-met proteins in gastric adenoma and adenocarcinoma].
Lee SW; Kang SB; Kim YS; Nam SW; Lee DS; Lee HK; Han SW
Korean J Gastroenterol; 2007 Mar; 49(3):152-7. PubMed ID: 18172343
[TBL] [Abstract][Full Text] [Related]
47. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
Gürel S; Dolar E; Yerci O; Samli B; Oztürk H; Nak SG; Gülten M; Memik F
J Int Med Res; 1999; 27(2):74-8. PubMed ID: 10446693
[TBL] [Abstract][Full Text] [Related]
48. Correlation of c-erbB-2 protein expression and lymph node status in early gastric cancer.
Yonemura Y; Ninomiya I; Ohoyama S; Fushida S; Kimura H; Tsugawa K; Kamata T; Yamaguchi A; Miyazaki I; Endou Y
Oncology; 1992; 49(5):363-7. PubMed ID: 1356259
[TBL] [Abstract][Full Text] [Related]
49. Subclassification of extranodal involvement in gastric cancer patients.
Nakamura K; Ogoshi K; Makuuchi H
Hepatogastroenterology; 2010; 57(101):968-74. PubMed ID: 21033261
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.
Lee HR; Kim JH; Uhm HD; Ahn JB; Rha SY; Cho JY; Lee JI; Lee KH; Chung HC; Roh JK; Min JS; Lee KS; Shin DH; Kim BS; Hong SW; Choi JH
Oncology; 1996; 53(3):192-7. PubMed ID: 8643220
[TBL] [Abstract][Full Text] [Related]
51. c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.
Pinto-de-Sousa J; David L; Almeida R; Leitão D; Preto JR; Seixas M; Pimenta A
Int J Surg Pathol; 2002 Oct; 10(4):247-56. PubMed ID: 12490974
[TBL] [Abstract][Full Text] [Related]
52. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
[TBL] [Abstract][Full Text] [Related]
53. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
Chariyalertsak S; Sugano K; Ohkura H; Mori Y
Tumour Biol; 1994; 15(5):294-303. PubMed ID: 7991990
[TBL] [Abstract][Full Text] [Related]
54. Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma.
Yonemura Y; Ninomiya I; Ohoyama S; Kimura H; Yamaguchi A; Fushida S; Kosaka T; Miwa K; Miyazaki I; Endou Y
Cancer; 1991 Jun; 67(11):2914-8. PubMed ID: 1673870
[TBL] [Abstract][Full Text] [Related]
55. Expression of c-erbB-2 oncoprotein in gastric carcinoma: correlation with histopathologic characteristics and analysis of Ki-67.
Dursun A; Poyraz A; Celik B; Akyol G
Pathol Oncol Res; 1999; 5(2):104-6. PubMed ID: 10393360
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of vimentin expression and Her-2 status in patients with gastric carcinoma.
Zhao W; Yue L; Zhou F; Xu C; Liang W; Sui A; Ding A; Qiu W
Clin Transl Sci; 2013 Jun; 6(3):184-90. PubMed ID: 23751022
[TBL] [Abstract][Full Text] [Related]
57. C-erbB-2 oncoprotein in gastric carcinoma: correlation with clinical stage and prognosis.
Oshima CT; Lanzoni VP; Iriya K; Forones NM
Int J Biol Markers; 2001; 16(4):250-4. PubMed ID: 11820720
[TBL] [Abstract][Full Text] [Related]
58. Significant correlation between expression of interleukin-1alpha and liver metastasis in gastric carcinoma.
Tomimatsu S; Ichikura T; Mochizuki H
Cancer; 2001 Apr; 91(7):1272-6. PubMed ID: 11283926
[TBL] [Abstract][Full Text] [Related]
59. Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach.
Yonemura Y; Ninomiya I; Tsugawa K; Fushida S; Fujimura T; Miyazaki I; Uchibayashi T; Endou Y; Sasaki T
Cancer Detect Prev; 1998; 22(2):139-46. PubMed ID: 9544434
[TBL] [Abstract][Full Text] [Related]
60. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma.
Ghaderi A; Vasei M; Maleck-Hosseini SA; Gharesi-Fard B; Khodami M; Doroudchi M; Modjtahedi H
Pathol Oncol Res; 2002; 8(4):252-6. PubMed ID: 12579211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
